Search Results - "Vázquez‐Borrego, Mari C."
-
1
Towards Understanding the Direct and Indirect Actions of Growth Hormone in Controlling Hepatocyte Carbohydrate and Lipid Metabolism
Published in Cells (Basel, Switzerland) (24-09-2021)“…Growth hormone (GH) is critical for achieving normal structural growth. In addition, GH plays an important role in regulating metabolic function. GH acts…”
Get full text
Journal Article -
2
Molecular evidence and clinical importance of β‐arrestins expression in patients with acromegaly
Published in Journal of cellular and molecular medicine (01-04-2018)“…β‐arrestins seem to have a role in endocytosis and desensitization of somatostatin receptor subtype 2 (sst2) and could be associated with the responsiveness to…”
Get full text
Journal Article -
3
Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms
Published in The journal of clinical endocrinology and metabolism (01-08-2019)“…Abstract Context Pituitary neuroendocrine tumors (PitNETs) are a commonly underestimated pathology in terms of incidence and associated morbimortality…”
Get full text
Journal Article -
4
Are there any completely sterile organs or tissues in the human body? Is there any sacred place?
Published in Microbial biotechnology (01-03-2024)“…The human microbiome comprises an ample set of organisms that inhabit and interact within the human body, contributing both positively and negatively to our…”
Get full text
Journal Article -
5
Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST5) in pituitary and pancreatic neuroendocrine tumors
Published in Molecular oncology (01-02-2022)“…Somatostatin receptor subtype 5 (SST5) is an emerging biomarker and actionable target in pituitary (PitNETs) and pancreatic (PanNETs) neuroendocrine tumors…”
Get full text
Journal Article -
6
A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells
Published in Neuroendocrinology (2020)“…Pituitary neuroendocrine tumors (PitNETs) represent approximately 15% of all intracranial tumors and usually are associated with severe comorbidities…”
Get more information
Journal Article -
7
The Pituitary Gland is a Novel Major Site of Action of Metformin in Non-Human Primates: a Potential Path to Expand and Integrate Its Metabolic Actions
Published in Cellular physiology and biochemistry (01-10-2018)“…Background/Aims: Biguanides are anti-hyperglycaemic agents used to treat diabetes by acting primarily on the liver, inhibiting hepatic gluconeogenesis…”
Get full text
Journal Article -
8
Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei
Published in Biological procedures online (15-05-2024)“…Pseudomyxoma peritonei (PMP) is a rare peritoneal mucinous carcinomatosis with largely unknown underlying molecular mechanisms. Cytoreductive surgery combined…”
Get full text
Journal Article -
9
Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series
Published in Frontiers in oncology (26-01-2023)“…Pseudomyxoma peritonei (PMP) is a rare malignant disease characterized by a massive multifocal accumulation of mucin within the peritoneal cavity. The current…”
Get full text
Journal Article -
10
Antitumor effect of a small-molecule inhibitor of KRASG12D in xenograft models of mucinous appendicular neoplasms
Published in Experimental hematology & oncology (08-12-2023)“…Pseudomyxoma peritonei (PMP) is a rare disease characterized by a massive accumulation of mucus in the peritoneal cavity. The only effective treatment is…”
Get full text
Journal Article -
11
Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3
Published in Brain (London, England : 1878) (01-11-2020)“…Glioblastomas remain the deadliest brain tumour, with a dismal ∼12-16-month survival from diagnosis. Therefore, identification of new diagnostic, prognostic…”
Get full text
Journal Article -
12
A Somatostatin Receptor Subtype-3 (SST 3 ) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors
Published in Clinical cancer research (15-02-2020)“…Somatostatin analogues (SSA) are efficacious and safe treatments for a variety of neuroendocrine tumors, especially pituitary neuroendocrine tumors (PitNET)…”
Get full text
Journal Article -
13
Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro
Published in Journal of endocrinology (01-11-2016)“…Somatostatin analogs (SSA) are the mainstay of pharmacological treatment for pituitary adenomas. However, some patients escape from therapy with octreotide, a…”
Get full text
Journal Article -
14
Integrative Clinical, Radiological, and Molecular Analysis for Predicting Remission and Recurrence of Cushing Disease
Published in The journal of clinical endocrinology and metabolism (16-06-2022)“…Adrenocorticotropin (ACTH)-secreting pituitary tumors (ACTHomas) are associated with severe comorbidities and increased mortality. Current treatments mainly…”
Get full text
Journal Article -
15
Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles
Published in Scientific reports (04-02-2019)“…Filamin-A (FLNA) plays a crucial role in somatostatin receptor (sst) subtype-2 signaling in somatotropinomas. Our objective was to investigate the in vivo…”
Get full text
Journal Article -
16
Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features
Published in Cancers (26-09-2019)“…Pituitary neuroendocrine tumors (PitNETs) constitute approximately 15% of all brain tumors, and most have a sporadic origin. Recent studies suggest that…”
Get full text
Journal Article -
17
Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas
Published in Scientific reports (18-04-2018)“…Acromegaly is a rare but severe disease, originated in 95% of cases by a growth hormone-secreting adenoma (somatotropinoma) in the pituitary. Magnetic…”
Get full text
Journal Article -
18
BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas
Published in Scientific reports (09-02-2017)“…Chimeric somatostatin/dopamine compounds such as BIM-23A760, an sst2/sst5/D 2 receptors-agonist, have emerged as promising new approaches to treat pituitary…”
Get full text
Journal Article -
19
E‐cadherin expression is associated with somatostatin analogue response in acromegaly
Published in Journal of cellular and molecular medicine (01-05-2019)“…Acromegaly is a rare disease resulting from hypersecretion of growth hormone (GH) and insulin‐like growth factor 1 (IGF1) typically caused by pituitary…”
Get full text
Journal Article -
20
Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
Published in Journal of cellular and molecular medicine (01-03-2018)“…Acromegaly is a hormonal disorder resulting from excessive growth hormone (GH) secretion frequently produced by pituitary adenomas and consequent increase in…”
Get full text
Journal Article